HomeORCHPHARMA • NSE
add
Orchid Pharma Ltd
Previous close
₹672.20
Day range
₹652.20 - ₹687.25
Year range
₹603.80 - ₹1,214.95
Market cap
33.98B INR
Avg Volume
57.68K
P/E ratio
65.00
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 2.07B | -4.64% |
Operating expense | 715.86M | -4.29% |
Net income | -126.14M | -160.71% |
Net profit margin | -6.09 | -163.70% |
Earnings per share | -1.08 | — |
EBITDA | 10.45M | -95.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.49B | -39.11% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 12.74B | — |
Shares outstanding | 50.66M | — |
Price to book | 2.67 | — |
Return on assets | — | — |
Return on capital | -1.20% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -126.14M | -160.71% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Founded
1992
Website
Employees
736
